These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2474975)

  • 1. [Chronic inflammatory bowel diseases: immunologic changes--cause or epiphenomenon?].
    Zeitz M
    Z Gastroenterol Verh; 1989 Jul; 24():26-30. PubMed ID: 2474975
    [No Abstract]   [Full Text] [Related]  

  • 2. Characteristics of isolated intestinal mucosal lymphoid cells in inflammatory bowel disease.
    Bookman MA; Bull DM
    Gastroenterology; 1979 Sep; 77(3):503-10. PubMed ID: 313352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel disease.
    Fiocchi C; Hilfiker ML; Youngman KR; Doerder NC; Finke JH
    Gastroenterology; 1984 Apr; 86(4):734-42. PubMed ID: 6607860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell apoptosis and inflammatory bowel disease.
    Peppelenbosch MP; van Deventer SJ
    Gut; 2004 Nov; 53(11):1556-8. PubMed ID: 15479669
    [No Abstract]   [Full Text] [Related]  

  • 5. [Autoantibodies in chronic inflammatory bowel diseases: more than an epiphenomenon?].
    Folwaczny C; Fricke H
    Z Gastroenterol; 1998 Jan; 36(1):105-8. PubMed ID: 9531690
    [No Abstract]   [Full Text] [Related]  

  • 6. The immunology of inflammatory bowel disease.
    MacKechnie HL
    Henry Ford Hosp Med J; 1982; 30(1):25-32. PubMed ID: 6123493
    [No Abstract]   [Full Text] [Related]  

  • 7. [Etiology and pathogenesis of Crohn disease and ulcerative colitis].
    Knoflach P
    Wien Klin Wochenschr; 1986 Nov; 98(22):754-8. PubMed ID: 3811368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppression in the treatment of inflammatory bowel disease. I. Changes in lymphoid sub-populations in the blood and rectal mucosa following cessation of treatment with azathioprine.
    Campbell AC; Skinner JM; Hersey P; Roberts-Thomson P; MacLennan IC; Truelove SC
    Clin Exp Immunol; 1974 Apr; 16(4):521-33. PubMed ID: 4468852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological aspects of inflammatory bowel disease.
    Whorwell PJ; Wright R
    Clin Gastroenterol; 1976 May; 5(2):303-21. PubMed ID: 1037288
    [No Abstract]   [Full Text] [Related]  

  • 10. [Functional status of intestinal t lymphocytes, regulatory mechanisms, and their variations in the course of Crohn disease and ulcerative colitis].
    Boirivant M; Marini M; Di Felice G
    Ann Ist Super Sanita; 1999; 35(2):283-9. PubMed ID: 10645662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular hypersensitivity in ulcerative colitis and Crohn's disease.
    Bendixen G
    Schweiz Med Wochenschr; 1971 May; 101(20):698-701. PubMed ID: 5578396
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of the innate immune system in the pathogenesis of inflammatory bowel disease.
    van Lierop PP; Samsom JN; Escher JC; Nieuwenhuis EE
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):142-51. PubMed ID: 19179875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunohistological study of T-lymphocytes (total and helper) and B-lymphocytes of the colonic mucosa in children with Crohn's disease and non-specific ulcerative colitis].
    Rodrigues M; Zerbini MC; Barbieri D
    Arq Gastroenterol; 1998; 35(3):223-36. PubMed ID: 10029869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunologic basis of inflammatory bowel disease.
    Strober W; James SP
    J Clin Immunol; 1986 Nov; 6(6):415-32. PubMed ID: 2878011
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ulcerative colitis and Crohn disease from the immunologic viewpoint].
    Storch W
    Z Gesamte Inn Med; 1993 Feb; 48(2):49-51. PubMed ID: 8465545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated eosinophils in inflammatory bowel disease: do they matter?
    Desreumaux P; Nutten S; Colombel JF
    Am J Gastroenterol; 1999 Dec; 94(12):3396-8. PubMed ID: 10606287
    [No Abstract]   [Full Text] [Related]  

  • 17. Bowel diseases involving local immunoglobulin systems.
    Brandtzaeg P; Baklien K
    Acta Pathol Microbiol Scand Suppl; 1974; Suppl 248():43-60. PubMed ID: 4217555
    [No Abstract]   [Full Text] [Related]  

  • 18. Human intestinal mononuclear cells. I. Investigation of antibody-dependent, lectin-induced, and spontaneous cell-mediated cytotoxic capabilities.
    MacDermott RP; Franklin GO; Jenkins KM; Kodner IJ; Nash GS; Weinrieb IJ
    Gastroenterology; 1980 Jan; 78(1):47-56. PubMed ID: 7188608
    [No Abstract]   [Full Text] [Related]  

  • 19. Crypt hyperplasia related to increased lymphocyte activation in the rectal mucosa of children with ulcerative colitis.
    Arato A; Savilahti E; Paszti I
    Z Gastroenterol; 1994 Sep; 32(9):483-7. PubMed ID: 7801653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunologic findings in patients with chronic inflammatory bowel diseases. Crohn disease and ulcerative colitis].
    Remvig L; Davidsen B; Kristensen E
    Ugeskr Laeger; 1983 Apr; 145(17):1289-93. PubMed ID: 6349067
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.